Skip to Main Content

Author Details

Anne E Cress
University of Arizona Cancer Center, College of Medicine, University of Arizona
1977
145
40
PMIDPaper TitleJournal TitlePublished Year
36727054Digital image analysis using video microscopy of human-derived prostate cancer vs normal prostate organoids to assess migratory behavior on extracellular matrix proteins.Front Oncol2023
38046670Phenotype plasticity and altered sensitivity to chemotherapeutic agents in aggressive prostate cancer cells.Front Cell Dev Biol2023
37766428Biophysical phenotype mixtures reveal advantages for tumor muscle invasion in vivo.Biophys J2023
37042842PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.J Cell Biol2023
34139379Involvement of eNAMPT/TLR4 signaling in murine radiation pneumonitis: protection by eNAMPT neutralization.Transl Res2022
35856787An Actin-, Cortactin- and Ena-VASP-Linked Complex Contributes to Endothelial Cell Focal Adhesion and Vascular Barrier Regulation.Cell Physiol Biochem2022
35250607Integrin Beta 4E Promotes Endothelial Phenotypic Changes and Attenuates Lung Endothelial Cell Inflammatory Responses.Front Physiol2022
35328229GLUT3/SLC2A3 Is an Endogenous Marker of Hypoxia in Prostate Cancer Cell Lines and Patient-Derived Xenograft Tumors.Diagnostics (Basel)2022
35027578eNAMPT neutralization reduces preclinical ARDS severity via rectified NFkB and Akt/mTORC2 signaling.Sci Rep2022
35300411Integrins and Epithelial-Mesenchymal Cooperation in the Tumor Microenvironment of Muscle-Invasive Lethal Cancers.Front Cell Dev Biol2022
35167418eNAMPT Is a Novel Damage-associated Molecular Pattern Protein That Contributes to the Severity of Radiation-induced Lung Fibrosis.Am J Respir Cell Mol Biol2022
33326355CC16 Binding to α<sub>4</sub>β<sub>1</sub> Integrin Protects against <i>Mycoplasma pneumoniae</i> Infection.Am J Respir Crit Care Med2021
33586867EDC3 phosphorylation regulates growth and invasion through controlling P-body formation and dynamics.EMBO Rep2021
34959723A Humanized Monoclonal Antibody Targeting Extracellular Nicotinamide Phosphoribosyltransferase Prevents Aggressive Prostate Cancer Progression.Pharmaceuticals (Basel)2021
34631011EVL is a novel focal adhesion protein involved in the regulation of cytoskeletal dynamics and vascular permeability.Pulm Circ2021
34541033Loss of CDCP1 triggers FAK activation in detached prostate cancer cells.Am J Clin Exp Urol2021
34475475Essential role for paxillin tyrosine phosphorylation in LPS-induced mitochondrial fission, ROS generation and lung endothelial barrier loss.Sci Rep2021
34211090Direct phosphorylation and stabilization of HIF-1α by PIM1 kinase drives angiogenesis in solid tumors.Oncogene2021
33398621Cohesive cancer invasion of the biophysical barrier of smooth muscle.Cancer Metastasis Rev2021
33243842Endothelial eNAMPT amplifies pre-clinical acute lung injury: efficacy of an eNAMPT-neutralising monoclonal antibody.Eur Respir J2021
31477840Centrosome loss results in an unstable genome and malignant prostate tumors.Oncogene2020
33045468Role of secreted extracellular nicotinamide phosphoribosyltransferase (eNAMPT) in prostate cancer progression: Novel biomarker and therapeutic target.EBioMedicine2020
32736699A mutation found in esophageal cancer alters integrin β4 mRNA splicing.Biochem Biophys Res Commun2020
32565538Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer.Oncogene2020
30699045A method of quantifying centrosomes at the single-cell level in human normal and cancer tissue.Mol Biol Cell2019
33654897Immunofluorescence-based Determination of Centrosome Number in Tissue Samples.Bio Protoc2019
31731599A Method to Reuse Archived H&amp;E Stained Histology Slides for a Multiplex Protein Biomarker Analysis.Methods Protoc2019
31900909The Tumor Microenvironments of Lethal Prostate Cancer.Adv Exp Med Biol2019
31337652Gene Editing of α6 Integrin Inhibits Muscle Invasive Networks and Increases Cell-Cell Biophysical Properties in Prostate Cancer.Cancer Res2019
30865564Integrin α6β4E variant is associated with actin and CD9 structures and modifies the biophysical properties of cell-cell and cell-extracellular matrix interactions.Mol Biol Cell2019
29759989Novel Regulation of Integrin Trafficking by Rab11-FIP5 in Aggressive Prostate Cancer.Mol Cancer Res2018
30619287Spatial Mapping of Myeloid Cells and Macrophages by Multiplexed Tissue Staining.Front Immunol2018
29511352Regulation of inside-out β1-integrin activation by CDCP1.Oncogene2018
27509031Characterization of Laminin Binding Integrin Internalization in Prostate Cancer Cells.J Cell Biochem2017
28954241Targeting the Cohesive Cluster Phenotype in Chordoma via β1 Integrin Increases Ionizing Radiation Efficacy.Neoplasia2017
27609833A basal cell defect promotes budding of prostatic intraepithelial neoplasia.J Cell Sci2017
26239765Schwann Cells Increase Prostate and Pancreatic Tumor Cell Invasion Using Laminin Binding A6 Integrin.J Cell Biochem2016
26491047ATP promotes cell survival via regulation of cytosolic [Ca2+] and Bcl-2/Bax ratio in lung cancer cells.Am J Physiol Cell Physiol2016
27678419The Cohesive Metastasis Phenotype in Human Prostate Cancer.Biochim Biophys Acta2016
27158381Laminin-binding integrin gene copy number alterations in distinct epithelial-type cancers.Am J Transl Res2016
25485960Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors.Cancer Biol Ther2015
26572585Role of Integrin β4 in Lung Endothelial Cell Inflammatory Responses to Mechanical Stress.Sci Rep2015
26596768Nuclear factor, erythroid 2-like 2-associated molecular signature predicts lung cancer survival.Sci Rep2015
26697169Role played by paxillin and paxillin tyrosine phosphorylation in hepatocyte growth factor/sphingosine-1-phosphate-mediated reactive oxygen species generation, lamellipodia formation, and endothelial barrier function.Pulm Circ2015
25901201Combined micro CT and histopathology for evaluation of skeletal metastasis in live animals.Am J Transl Res2015
24739392Targeting integrin α6 stimulates curative-type bone metastasis lesions in a xenograft model.Mol Cancer Ther2014
25450398Intracellular modifiers of integrin alpha 6p production in aggressive prostate and breast cancer cell lines.Biochem Biophys Res Commun2014
21980133Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype.Mol Cancer Ther2011
22014040Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain.Mol Pain2011
21824975Macrophage-dependent cleavage of the laminin receptor α6β1 in prostate cancer.Mol Cancer Res2011
  • 1 - 50 of 145

Recommended Authors

University of Toronto
Career Start Year 2002
Number of shared co-authors 1
Foundation for the Finnish Cancer Institute
Career Start Year 1999
Number of shared co-authors 0
Cedars-Sinai Medical Center
Career Start Year 1997
Number of shared co-authors 13
The Francis Crick Institute
Career Start Year 1994
Number of shared co-authors 0
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
West Virginia University Cancer Institute, West Virginia University
Career Start Year 1993
Number of shared co-authors 0
Oklahoma Medical Research Foundation
Career Start Year 1992
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 1
University of California san francisco
Career Start Year 1992
Number of shared co-authors 0
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 1
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 2
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 3
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 0
MD Anderson Cancer Center
Career Start Year 1987
Number of shared co-authors 2
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year 1986
Number of shared co-authors 0
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 1
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 6
Sandra and Edward Meyer Cancer Center
Career Start Year 1983
Number of shared co-authors 3
Queen's University
Career Start Year 1982
Number of shared co-authors 2
Beth Israel Deaconess Medical Center and Harvard Medical School
Career Start Year 1981
Number of shared co-authors 5
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 6
The University of Texas Health Science Center at Houston School of Dentistry
Career Start Year 1981
Number of shared co-authors 2
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 4
Universite de Paris-Cite
Career Start Year 1979
Number of shared co-authors 0
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 2
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 1
University of Washington
Career Start Year 1974
Number of shared co-authors 3
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Career Start Year 1970
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 1

Collaborators

University of Utah
Co-authored papers 10
University of Massachusetts Chan School of Medicine
Co-authored papers 6
Co-authored papers 3
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 2
Faculty of Pharmacy, Medical University of Sofia
Co-authored papers 2
Helen Diller Family Comprehensive Cancer Center
Co-authored papers 2
Cedars-Sinai Medical Center
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Cedars-Sinai Medical Center 8700 Beverly Blvd
Co-authored papers 2
Mayo Clinic
Co-authored papers 2
University of Iowa
Co-authored papers 2
Cedars-Sinai Medical Center
Co-authored papers 2
Cedars-Sinai Medical Center 8700 Beverly Blvd
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Jonsson Comprehensive Cancer Center, university of california los angeles
Co-authored papers 1
Molecular Biology Institute, University of California los angeles
Co-authored papers 1
19University of Wisconsin Carbone Cancer Center.
Co-authored papers 1
University of California Irvine Irvine
Co-authored papers 1
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 1
Oregon Health & Science University
Co-authored papers 1
Herbert Wertheim College of Medicine
Co-authored papers 1
Cedars-Sinai Medical Center 8700 Beverly Blvd
Co-authored papers 1
Co-authored papers 1
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Co-authored papers 1
University of California los angeles
Co-authored papers 1
Cedars-Sinai Medical Center
Co-authored papers 1
Co-authored papers 1